INHIBITION OF HIV-1 REPLICATION BY A NONNUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITOR

被引:0
|
作者
SULLIVAN, JL
KOUP, RA
MERLUZZI, VJ
HARGRAVE, KD
ADAMS, J
GROZINGER, K
ECKNER, RJ
ROSENTHAL, AS
机构
[1] BOEHRINGER INGELHEIM PHARMACEUT INC,RIDGEFIELD,CT
[2] UNIV MASSACHUSETTS,SCH MED,DEPT PEDIAT,PROGRAM MOLEC MED,WORCESTER,MA 01605
来源
CLINICAL RESEARCH | 1991年 / 39卷 / 02期
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
引用
收藏
页码:A282 / A282
页数:1
相关论文
共 50 条
  • [21] MODELING AND CLASSIFICATION OF CHEMICALLY UNRELATED HIV-1 NONNUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITORS
    GUSSIO, R
    PATTABIRAMAN, N
    ZAHAREVITZ, DW
    KELLOGG, GE
    BURT, SK
    ERICKSON, JW
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1995, 209 : 107 - MEDI
  • [22] CRYSTAL-STRUCTURE OF NEVIRAPINE, A NONNUCLEOSIDE INHIBITOR OF HIV-1 REVERSE-TRANSCRIPTASE, AND COMPUTATIONAL ALIGNMENT WITH A STRUCTURALLY DIVERSE INHIBITOR
    MUI, PW
    JACOBER, SP
    HARGRAVE, KD
    ADAMS, J
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (01) : 201 - 202
  • [23] INHIBITION PATTERNS OF REVERSE-TRANSCRIPTASE BY NONNUCLEOSIDE INHIBITORS
    SPENCE, RA
    JIN, G
    KATI, WM
    JERVA, LF
    ANDERSON, KS
    JOHNSON, KA
    [J]. BIOPHYSICAL JOURNAL, 1993, 64 (02) : A178 - A178
  • [24] INHIBITION PATTERN OF REVERSE-TRANSCRIPTASE BY NONNUCLEOSIDE INHIBITORS
    SPENCE, RA
    KATI, WM
    JOHNSON, KA
    [J]. BIOPHYSICAL JOURNAL, 1994, 66 (02) : A369 - A369
  • [25] Nonnucleoside Reverse Transcriptase Inhibitor Hypersusceptibility and Resistance by Mutation of Residue 181 in HIV-1 Reverse Transcriptase
    Barnard, John P.
    Huber, Kelly D.
    Sluis-Cremer, Nicolas
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (08)
  • [26] CHARACTERIZATION OF THE ANTIVIRAL ACTIVITY OF HIGHLY SUBSTITUTED PYRROLES - A NOVEL CLASS OF NONNUCLEOSIDE HIV-1 REVERSE-TRANSCRIPTASE INHIBITOR
    ANTONUCCI, T
    WARMUS, JS
    HODGES, JC
    NICKELL, DG
    [J]. ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, 1995, 6 (02): : 98 - 108
  • [27] SYNTHESIS AND BIOLOGICAL EVALUATION OF AN ALKENYLDIARYLMETHANE (ADAM) WHICH ACTS AS A NOVEL NONNUCLEOSIDE HIV-1 REVERSE-TRANSCRIPTASE INHIBITOR
    CUSHMAN, M
    GOLEBIEWSKI, M
    BUCKHEIT, RW
    GRAHAM, L
    RICE, WG
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1995, 5 (22) : 2713 - 2716
  • [28] 2ND-GENERATION PETT NONNUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITORS OF HIV-1
    CANTRELL, A
    ENGELHARDT, P
    HATCH, SD
    JASKUNAS, SR
    JOHANSSON, NG
    JORDAN, CL
    KANGASMETSA, J
    KINNICK, MD
    LIND, P
    MAULDIN, SC
    MORIN, JM
    MUESING, MA
    MUNROE, JE
    NOREEN, R
    OBERG, B
    PRANC, P
    SAHLBERG, C
    TERNANSKY, RJ
    VASILEFF, RT
    VRANG, L
    WEST, SJ
    ZHANG, H
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1995, 210 : 94 - MEDI
  • [29] SYNTHESIS OF POTENT NONNUCLEOSIDE INHIBITORS OF HIV-1 REVERSE-TRANSCRIPTASE - TRICYCLIC DIBENZOXAZEPINONES AND PYRIDOBENZOXAZEPINONES
    WEST, M
    KLUNDER, JM
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1992, 203 : 14 - MEDI
  • [30] HIV-1 REVERSE-TRANSCRIPTASE - INHIBITION BY 2',5'-OLIGOADENYLATES
    SOBOL, RW
    FISHER, WL
    REICHENBACH, NL
    KUMAR, A
    BEARD, WA
    WILSON, SH
    CHARUBALA, R
    PFLEIDERER, W
    SUHADOLNIK, RJ
    [J]. BIOCHEMISTRY, 1993, 32 (45) : 12112 - 12118